HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysinuric Protein Intolerance

mutations in SLC7A7
Also Known As:
Dibasic Amino Aciduria II; Hyperdibasic Aminoaciduria; LPI - Lysinuric Protein Intolerance
Networked: 171 relevant articles (4 outcomes, 6 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hyperammonemia
2. Cystinuria
3. Osteoporosis
4. Inborn Genetic Diseases (Disease, Hereditary)
5. Hartnup Disease

Experts

1. Näntö-Salonen, Kirsti: 11 articles (01/2017 - 07/2003)
2. Simell, Olli: 11 articles (01/2016 - 03/2002)
3. Niinikoski, Harri: 10 articles (01/2017 - 02/2006)
4. Sebastio, Gianfranco: 7 articles (10/2019 - 08/2004)
5. Dionisi-Vici, Carlo: 6 articles (01/2022 - 08/2004)
6. Mykkänen, Juha: 6 articles (01/2017 - 03/2002)
7. Barilli, Amelia: 5 articles (01/2020 - 11/2010)
8. Dall'Asta, Valeria: 5 articles (01/2020 - 11/2010)
9. Rotoli, Bianca Maria: 5 articles (01/2020 - 11/2010)
10. Visigalli, Rossana: 5 articles (01/2020 - 11/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lysinuric Protein Intolerance:
1. Arginine (L-Arginine)FDA Link
2. OrnithineIBA
3. Lysine (L-Lysine)FDA Link
4. Proteins (Proteins, Gene)FDA Link
5. Growth Hormone (Somatotropin)IBA
6. AcidsIBA
7. CitrullineIBA
8. IronIBA
9. Ferritins (Ferritin)IBA
10. Carnitine (L-Carnitine)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Kidney Transplantation
3. Oral Administration
4. Hematopoietic Stem Cell Transplantation
5. Renal Replacement Therapy (Therapies, Renal Replacement)